PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer

BACKGROUND: Immunotherapy targeting programmed cell death 1 (PD-1) or its ligand 1 (PD-L1) has shown promising results in non-small cell lung cancer (NSCLC) patients. Exploring PD-L1 expression could help to select NSCLC candidates for immunotherapy. Fluorine-18 fluorodeoxyglucose (FDG) PET/CT could...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaodong, Huang, Yan, Zhao, Qingping, Wang, Lei, Song, Xiao, Li, Yi, Jiang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237589/
https://www.ncbi.nlm.nih.gov/pubmed/32430866
http://dx.doi.org/10.1186/s13550-020-00639-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237589/
https://www.ncbi.nlm.nih.gov/pubmed/32430866
http://dx.doi.org/10.1186/s13550-020-00639-9

Ejemplares similares